China Stock Analysis

SXTC -  USA Stock  

USD 0.19  0.02  9.52%

The big decline in price over the last few months for China Sxt Pharmaceuticals created some momentum for investors as it was traded today as low as 0.18 and as high as 0.2 per share. The company executives failed to add value to investors and positioning the firm supply of money to exploit market volatility in December. However, diversifying your holdings with China Sxt Pharmaceuticals or any similar stocks can still protect your portfolios during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 9.51. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the China Sxt partners.
Additionally, take a look at World Market Map.

China Stock Analysis 

The China Sxt stock analysis report makes it easy to digest most publicly released information about China Sxt and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. China Stock analysis module also helps to analyze the China Sxt price relationship with some important fundamental indicators such as market cap and management efficiency.

China Stock Analysis Notes

About 20.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.2. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. China Sxt Pharmaceuticals recorded a loss per share of 0.19. The entity had not issued any dividends in recent years. The firm had a split on the 22nd of February 2021. China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine piece tablets in China. The company was founded in 2005 and is based in Taizhou, China. China Sxt is traded on NASDAQ Exchange in the United States. To find out more about China Sxt Pharmaceuticals contact the company at 86 523 8629 8290 or learn more at

China Sxt Pharmaceuticals Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. China Sxt's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding China Sxt Pharmaceuticals or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
China Sxt generated a negative expected return over the last 90 days
China Sxt has high historical volatility and very poor performance
China Sxt has some characteristics of a very speculative penny stock
China Sxt has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 4.78 M. Net Loss for the year was (2.75 M) with profit before overhead, payroll, taxes, and interest of 2.84 M.
China Sxt Pharmaceuticals currently holds about 13.33 M in cash with (1.32 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.86, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Roughly 20.0% of the company outstanding shares are owned by corporate insiders
Latest headline from Sector Update Health Care Fall Tuesday But Resist Steepest Declines - InvestorsObserver

China Market Capitalization

The company currently falls under 'Nano-Cap' category with current market capitalization of 3.12 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate China Sxt's market, we take the total number of its shares issued and multiply it by China Sxt's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

China Profitablity

China Sxt's profitability indicators refer to fundamental financial ratios that showcase China Sxt's ability to generate income relative to its revenue or operating costs. If, let's say, China Sxt is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, China Sxt's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of China Sxt's profitability requires more research than a typical breakdown of China Sxt's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (57.52) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (45.99) %, which suggests for every $100 dollars of sales, it generated a net operating loss of -0.46.

Management Efficiency

The entity has return on total asset (ROA) of (4.88) % which means that it has lost $4.88 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (21.67) %, meaning that it created substantial loss on money invested by shareholders. China Sxt management efficiency ratios could be used to measure how well china sxt pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 26th of January, China Sxt shows the risk adjusted performance of (0.14), and Mean Deviation of 5.33. In respect to fundamental indicators, the technical analysis model gives you tools to check existing technical drivers of China Sxt, as well as the relationship between them. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to interpolate and analyze data for nineteen technical drivers for China Sxt Pharmaceuticals, which can be compared to its rivals. Please confirm China Sxt Pharmaceuticals coefficient of variation, treynor ratio, as well as the relationship between the Treynor Ratio and semi variance to decide if China Sxt Pharmaceuticals is priced correctly, providing market reflects its regular price of 0.19 per share. As China Sxt Pharmaceuticals appears to be a penny stock we also recommend to validate its total risk alpha numbers.

China Sxt Pharmaceuticals Price Movement Analysis

The output start index for this execution was one with a total number of output elements of sixty. The Simple Moving Average indicator is calculated by adding the closing price of China Sxt for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out China Sxt Pharmaceuticals short-term fluctuations and highlight longer-term trends or cycles. View also all equity analysis or get more info about simple moving average overlap studies indicator.

China Sxt Technical and Predictive Indicators

China Sxt Forecast Models

China Sxt time-series forecasting models is one of many China Sxt's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary China Sxt's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About China Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how China Sxt stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling China shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as China Sxt. By using and applying China Stock analysis, traders can create a robust methodology for identifying China entry and exit points for their positions.
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine piece tablets in China. The company was founded in 2005 and is based in Taizhou, China. China Sxt is traded on NASDAQ Exchange in the United States.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding China Sxt to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Global Markets Map Now


Global Markets Map

Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
All  Next Launch Module
Additionally, take a look at World Market Map. Note that the China Sxt Pharmaceuticals information on this page should be used as a complementary analysis to other China Sxt's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Complementary Tools for China Stock analysis

When running China Sxt Pharmaceuticals price analysis, check to measure China Sxt's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy China Sxt is operating at the current time. Most of China Sxt's value examination focuses on studying past and present price action to predict the probability of China Sxt's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move China Sxt's price. Additionally, you may evaluate how the addition of China Sxt to your portfolios can decrease your overall portfolio volatility.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Bond Directory
Find actively traded corporate debentures issued by US companies
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Money Managers
Screen money managers from public funds and ETFs managed around the world
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Fundamental Analysis
View fundamental data based on most recent published financial statements
Transaction History
View history of all your transactions and understand their impact on performance
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Is China Sxt's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of China Sxt. If investors know China will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about China Sxt listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of China Sxt Pharmaceuticals is measured differently than its book value, which is the value of China that is recorded on the company's balance sheet. Investors also form their own opinion of China Sxt's value that differs from its market value or its book value, called intrinsic value, which is China Sxt's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because China Sxt's market value can be influenced by many factors that don't directly affect China Sxt's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between China Sxt's value and its price as these two are different measures arrived at by different means. Investors typically determine China Sxt value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, China Sxt's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.